Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who purchased Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2025, and November 12, 2025, alleging that the company misled investors regarding its accounts receivable [1][2]. Allegations - The complaint states that Ardent Health reported inflated accounts receivable and delayed recognizing losses on uncollectible accounts [2]. - It is alleged that Ardent Health did not maintain sufficient professional malpractice liability insurance to cover claims arising from its operations [2]. - On November 12, 2025, Ardent Health disclosed a $43 million decrease in third quarter 2025 revenue due to revised assessments of accounts receivable collectability, which led to a significant drop in stock price from $14.05 to $9.30 per share, a decline of nearly 34% [2]. Next Steps - Shareholders interested in serving as lead plaintiffs in the class action against Ardent Health, Inc. are encouraged to contact Robbins LLP [3]. - Shareholders can choose to remain absent class members without participating in the case while still being eligible for recovery [3].
Investor Notice: Robbins LLP Informs Investors of the Ardent Health, Inc. Securities Class Action